186.70
+13.95
+(8.08%)
At close: April 17 at 5:35:33 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,857,700
2,780,000
2,775,500
3,492,700
2,887,000
Cost of Revenue
1,603,400
1,573,300
1,541,500
1,675,400
1,334,000
Gross Profit
1,254,300
1,206,700
1,234,000
1,817,400
1,553,000
Operating Expense
828,300
811,500
766,600
762,400
670,000
Operating Income
426,000
395,200
467,400
1,055,000
883,000
Net Non Operating Interest Income Expense
-132,700
-140,000
-115,800
-9,700
-6,700
Pretax Income
257,200
219,200
401,900
1,130,400
646,700
Tax Provision
50,600
40,700
89,200
250,500
232,400
Net Income Common Stockholders
204,300
175,100
310,300
876,100
414,400
Diluted NI Available to Com Stockholders
204,300
175,100
310,300
876,100
414,400
Basic EPS
2.11
1.81
3.37
9.51
4.50
Diluted EPS
2.11
1.81
3.37
9.51
4.50
Basic Average Shares
96,785.13
96,777.30
92,160.63
92,163.10
92,176.83
Diluted Average Shares
96,785.13
96,777.30
92,160.63
92,163.10
92,176.83
Total Operating Income as Reported
--
370,600
449,500
995,200
865,421
Total Expenses
2,431,700
2,384,800
2,308,100
2,437,800
2,004,000
Net Income from Continuing & Discontinued Operation
204,300
175,100
310,300
876,100
414,400
Normalized Income
231,611.04
202,776
260,663.60
777,760.80
567,278.50
Interest Income
40,800
18,900
6,200
500
300
Interest Expense
164,200
149,600
117,000
18,600
10,400
Net Interest Income
-132,700
-140,000
-115,800
-9,700
-6,700
EBIT
421,400
368,800
518,900
1,149,000
657,100
EBITDA
730,500
670,500
755,700
1,330,700
798,700
Reconciled Cost of Revenue
1,603,400
1,573,300
1,541,500
1,675,400
1,334,000
Reconciled Depreciation
309,100
301,700
236,800
181,700
141,600
Net Income from Continuing Operation Net Minority Interest
204,300
175,100
310,300
876,100
414,400
Total Unusual Items Excluding Goodwill
-34,000
-34,000
63,800
126,400
-238,500
Total Unusual Items
-34,000
-34,000
63,800
126,400
-238,500
Normalized EBITDA
764,500
704,500
691,900
1,204,300
1,037,200
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,688.96
-6,324
14,163.60
28,060.80
-85,621.50
12/31/2021 - 2/5/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BOX.DE Becton, Dickinson and Company
176.50
-1.89%
BIG1.DE Bio-Gate AG
0.8400
0.00%
SUVPF Sartorius Aktiengesellschaft
198.85
0.00%
ESL.DE EssilorLuxottica Société anonyme
253.10
-0.16%
IUI1.DE Intuitive Surgical, Inc.
428.60
-0.92%
CBHD.DE Coloplast A/S
93.60
-1.33%
SSSGY Sartorius Aktiengesellschaft
39.00
0.00%
FIE.DE Fielmann Group AG
43.55
+0.11%
1SXP.DE SCHOTT Pharma AG & Co. KGaA
23.05
+1.54%
SRT.DE Sartorius Aktiengesellschaft
172.60
-1.93%